CIK 0001430306 · Non-accelerated filer<br>Smaller reporting company
Tonix Pharmaceuticals Holding Corp.
Sign in to watch- Ticker
- TNXP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- operating
- EIN
- 261434750
- Phone
- 212-980-9155
- Business address
- 200 CONNELL DRIVE, SUITE 3100, BERKELEY HEIGHTS, NJ, 07922
- Former names
- TAMANDARE EXPLORATIONS INC.
- Open-market buys, last 90 days
- $60,455
- in 3 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$60,455. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-05-06 | GRACE PATRICK P Director | Grant or award · Stock Option | +30,000 | 30,000 | ||
| 2019-05-06 | OLUKOTUN ADEOYE Y Director | Grant or award · Stock Option | +30,000 | 30,000 | ||
| 2019-05-06 | Treco James Director | Grant or award · Stock Option | +30,000 | 30,000 | ||
| 2019-05-06 | Bell Margaret Smith Director | Grant or award · Stock Option | +30,000 | 30,000 | ||
| 2019-05-06 | Rhodes John B Director | Grant or award · Stock Option | +45,000 | 45,000 | ||
| 2019-03-29 | LEDERMAN SETH Chief Executive Officer | Purchase | +5,000 | $2.49 | $12K | 32,670 |
| 2019-03-26 | LEDERMAN SETH Chief Executive Officer | Purchase | +25,000 | $2.38 | $59K | 27,670 |
| 2019-02-26 | SAENGER BRADLEY Chief Financial Officer | Grant or award · Stock Option | +5,170 | 5,170 | ||
| 2019-02-26 | SAENGER BRADLEY Chief Financial Officer | Grant or award · Stock Option | +5,170 | 5,170 | ||
| 2019-02-26 | MORRIS JESSICA EDGAR Chief Operating Officer | Grant or award · Common Stock | +5,170 | 5,170 | ||
| 2019-02-26 | MORRIS JESSICA EDGAR Chief Operating Officer | Grant or award · Common Stock | +5,170 | 5,170 | ||
| 2019-02-26 | SULLIVAN GREGORY M Chief Medical Officer | Grant or award · Stock Option | +7,755 | 7,755 | ||
| 2019-02-26 | SULLIVAN GREGORY M Chief Medical Officer | Grant or award · Stock Option | +7,755 | 7,755 | ||
| 2019-02-26 | LEDERMAN SETH Chief Executive Officer | Grant or award · Stock Option | +23,265 | 23,265 | ||
| 2019-02-26 | LEDERMAN SETH Chief Executive Officer | Grant or award · Stock Option | +23,265 | 23,265 | ||
| 2019-02-14 | Treco James Director | Grant or award · Stock Option | +10,000 | 10,000 | ||
| 2018-09-05 | OLUKOTUN ADEOYE Y Director | Grant or award · Stock Option | +15,000 | 15,000 | ||
| 2018-06-29 | LEDERMAN SETH Chief Executive Officer | Purchase | +500 | $4.64 | $2K | 17,666 |
| 2018-06-28 | LEDERMAN SETH Chief Executive Officer | Purchase | +500 | $4.58 | $2K | 17,166 |
| 2018-06-27 | LEDERMAN SETH Chief Executive Officer | Purchase | +500 | $4.55 | $2K | 16,666 |
Page 10 of 25 · 482 trades